Abbott (NYSE:ABT) said today that the FDA approved its 14-day FreeStyle Libre flash glucose monitor, making the device the longest lasting self-applied glucose sensor on the market.
The company’s FreeStyle Libre system, initially approved to last 10 days, is designed to eliminate the need for fingersticks. Users can test their blood sugar with the continuous glucose monitor by simply swiping a phone over a small sensor worn on their upper arm.
Get the full story at our sister site, Drug Delivery Business News.
The post Abbott wins FDA nod for 14-day FreeStyle Libre glucose sensor appeared first on MassDevice.
from MassDevice https://ift.tt/2LVq5Nx
Cap comentari:
Publica un comentari a l'entrada